THE BIOMARKER-PRIMED RECOVERY MODEL: SYNERGISTIC MODULATION OF THE IDOL-LRP1 PATHWAY AND METABOLIC FLUX TO OPTIMIZE FUNCTIONAL MOTOR REHABILITATION IN ALZHEIMER’S DISEASE

Abstract

Multimodal neurorehabilitation, driven by biomarkers, is an important step towards treating Alzheimer's disease, as it overcomes the weaknesses of single-target therapy. This integrative approach is based on molecular priming, metabolic optimization, and precision-based rehabilitation to boost neuroplasticity and functional recovery. The main focus of this plan is the regulation of the IDOL-LRP1 system, which promotes amyloid-beta clearance and synaptic integrity, and the application of GLP-1 receptor agonists in order to normalize cerebral energy metabolism and mitochondrial activity. Neural priming is a critical notion, since it equips the biological substrate to react more favourably to the rehabilitative interventions. Planned protocols that involve high-intensity interval training and robot-assisted gait training also enhance synaptic remodelling and integration of motor pathways. Moreover, bio-digital integration with wearable sensors and adaptive feedback systems will provide an opportunity to monitor patient performance in real-time, as well as constantly adjust the intensity of the therapy. This individual treatment means that rehabilitation is related to biological readiness of the patient and offers the maximum of therapeutic effects. All in all, these strategies are not only able to maximize quick recovery, but also long-term sustainability of cognitive and motor improvements, which is a promising trend in future neurorestorative therapies.